abstract: Does Neoadjuvant (Avastin) Bevacizumab Increase Surgical Complications in Breast Surgery? Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, October 02, 2010

abstract: Does Neoadjuvant (Avastin) Bevacizumab Increase Surgical Complications in Breast Surgery?



Conclusions Cisplatin/bevacizumab and cisplatin alone neoadjuvant therapy resulted in a significant number of postoperative complications. Specifically, use of expanders/implants may be problematic for patients treated with bev. However, this was a single-arm trial; randomized controlled studies will be needed to determine the optimal use of bevacizumab in the timing of breast cancer surgery.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.